Corporate News

AACR 2026 Special Report: An In-Depth Review of Medicilon’s Three Technical Posters | Bilingual
Medicilon Signs Five-Year Strategic Cooperation Agreement with BioPartners X to Jointly Promote Innovative Drug R&D
Medicilon and Protheragen Forge Strategic Partnership to Build a Collaborative “Project + Platform” Model
AOC Development: Conjugation Site Selection, DAR Control & In Vitro Testing | Full Webinar
Medicilon and Hailu Biotech of Yangtze River Pharmaceutical Group Forge Strategic Cooperation to Accelerate New Drug R&D and Global Outreach
Medicilion Congratulates MediLink Therapeutics on Licensing B7H3 ADC to Roche

Events

ASMS 2026
KSNS 2026
Nordic PMF 2026
ICDD 2026
BioTrinity 2026
Oligonucleotide Therapeutics: Conjugation Chemistry & In Vitro Activity Assessment

Medicilon Academy

【Case Study】New Approach Methods NAMs
【Case Study】Route, Solid-State, and Impurity Optimization (Small-Molecule API)
【Case Study】IND Completion in 12 Months (Small-Molecule NCE)
Boston Non-Tumor Models Innovation
【White Paper】Navigating the DMPK Gauntlet: A Strategic Analysis of the Interconnected Challenges Shaping the Future of Drug Development
【White Paper】Patient-Derived Xenograft Organoids: Advancements and Applications in Precision Oncology

Digital Materials

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)
Integrated Mass Spectrometric Workflows Enabling Next-Generation Conjugate Therapeutics in Cancer Research (Download)
From Sequence Design to AOC Production Medicilon’ s End-to-End RNAi Development Platform (Download)
Developing PDX-Derived Organoid Models for Efficacy Evaluation of Anticancer Therapies (Download)
Boston Innovation Meets ADME Precision
Medicilon—Developing PDX-Derived Organoid Models for Efficacy Evaluation of Anticancer Therapies (Download)

Search Medicilon

Leveraging a Humanized SLE Mouse Model to Evaluate Next-Generation Immune-Cell-Targeted Therapeutics (Download)

Integrated Mass Spectrometric Workflows Enabling Next-Generation Conjugate Therapeutics in Cancer Research (Download)

From Sequence Design to AOC Production Medicilon’ s End-to-End RNAi Development Platform (Download)

Contact Medicilon

Name(Required)
Address(Required)